Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Offidani

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2020
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscoreA V Marzano, A Chiricozzi, G Giovanardi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2009
Caspofungin for the treatment of candidaemia in patients with haematological malignanciesL Pagano, L Fianchi, R Fanci, et al.
Haematologica|September 8, 1999
Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study GroupS Rupoli, S Barulli, B Guiducci, et al.
Italian Journal of Dermatology and Venereology|April 18, 2025
Italian Consensus on the treatment of oral lichen planusElisa Cinotti, Martina D'Onghia, Laura Calabrese, et al.
Leukemia|December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaS Bringhen, M D'Agostino, L De Paoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2020
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experienceM C Fargnoli, M Esposito, P Dapavo, et al.
Clinical and Experimental Dermatology|December 30, 2018
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohortL Bianchi, R D Caposiena Caro, G Ganzetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie MaligneL Pagano, M Caira, A Nosari, et al.
Journal of Internal Medicine|February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial HypertensionS Bringhen, A Milan, M D'Agostino, et al.
Blood Cancer Journal|November 26, 2013
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II studyM Offidani, L Corvatta, L Maracci, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2020
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscoreA V Marzano, A Chiricozzi, G Giovanardi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2009
Caspofungin for the treatment of candidaemia in patients with haematological malignanciesL Pagano, L Fianchi, R Fanci, et al.
Haematologica|September 8, 1999
Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study GroupS Rupoli, S Barulli, B Guiducci, et al.
Italian Journal of Dermatology and Venereology|April 18, 2025
Italian Consensus on the treatment of oral lichen planusElisa Cinotti, Martina D'Onghia, Laura Calabrese, et al.
Leukemia|December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaS Bringhen, M D'Agostino, L De Paoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2020
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experienceM C Fargnoli, M Esposito, P Dapavo, et al.
Clinical and Experimental Dermatology|December 30, 2018
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohortL Bianchi, R D Caposiena Caro, G Ganzetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie MaligneL Pagano, M Caira, A Nosari, et al.
Journal of Internal Medicine|February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial HypertensionS Bringhen, A Milan, M D'Agostino, et al.
Blood Cancer Journal|November 26, 2013
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II studyM Offidani, L Corvatta, L Maracci, et al.
Pageof 6